Novartis reports positive results in spinal inflammation condition

Novartis reports positive results in spinal inflammation condition

(Reuters) – Swiss drugmaker Novartis said on Thursday two late-stage trials showed its drug secukinumab improved symptoms of ankylosing spondylitis, a debilitating joint condition of the spine.

The trials, which involved a total of approximately 600 patients, found Novartis’ drug improved signs and symptoms of the disease as well as physical function and quality of life compared with placebo.

The results follow on from positive findings for the anti-inflammation drug in a type of arthritis associated with the skin disease psoriasis last month.

Novartis plans to file for regulatory approval of secukinumab to treat ankylosing spondylitis and psoriatic arthritis in 2015.

Earlier this week, an advisory panel to the U.S. Food and Drug Administration unanimously recommended the use of secukinumab in patients with a type of psoriasis, paving the way for its approval.

(Reporting by Caroline Copley)

Read the original here:
feeds.reuters

Healthy Living News From around The Web
Novartis reports positive results in spinal inflammation condition – Reuters

Google+

Dopps Chiropractic
4746 S. Broadway
WichitaKs 67216

(316) 522-1122
http://ift.tt/14R1IJ3
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s